- Home
- Publications
- Publication Search
- Publication Details
Title
In perspective: An update on telomere targeting in cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-07
DOI
10.1002/mc.23035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- (2018) Gao Zhang et al. CLINICAL CANCER RESEARCH
- Correlation between telomerase and mTOR pathway in cancer stem cells
- (2018) Fatma Dogan et al. GENE
- Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
- (2018) Satarupa Sengupta et al. MOLECULAR CANCER THERAPEUTICS
- Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
- (2018) Patricia Reyes-Uribe et al. ONCOGENE
- Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
- (2018) Ilgen Mender et al. NEOPLASIA
- Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells
- (2018) Fatma Doğan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Overexpression of cellular telomerase RNA enhances virus-induced cancer formation
- (2018) Ahmed Kheimar et al. ONCOGENE
- MYC drives overexpression of telomerase RNA (hTR /TERC ) in prostate cancer
- (2017) Javier A Baena-Del Valle et al. JOURNAL OF PATHOLOGY
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- Reactivation of telomerase in cancer
- (2016) Semih Can Akincilar et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2016) Ralph Salloum et al. JOURNAL OF NEURO-ONCOLOGY
- Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
- (2016) Robin E. Frink et al. Oncotarget
- Regulation of the Human Telomerase Gene TERT by Telomere Position Effect—Over Long Distances (TPE-OLD): Implications for Aging and Cancer
- (2016) Wanil Kim et al. PLOS BIOLOGY
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
- (2015) R. L. Flynn et al. SCIENCE
- Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532
- (2015) Christopher Bryan et al. STRUCTURE
- TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
- (2015) Kun Wang et al. Oncotarget
- A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
- (2014) A. A. Chiappori et al. ANNALS OF ONCOLOGY
- An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity
- (2014) F. S. Gazzaniga et al. BLOOD
- Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2′-Deoxyguanosine
- (2014) Ilgen Mender et al. Cancer Discovery
- TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- (2013) P. S. Rachakonda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells
- (2012) Davood Bashash et al. LEUKEMIA & LYMPHOMA
- Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells
- (2012) Z Liu et al. ONCOGENE
- Cancer and Telomeres--An ALTernative to Telomerase
- (2012) J. W. Shay et al. SCIENCE
- Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
- (2012) E Fokas et al. Cell Death & Disease
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
- (2011) Christopher M. Heaphy et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of telomeres and telomerase in cancer
- (2011) Jerry W. Shay et al. SEMINARS IN CANCER BIOLOGY
- hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells
- (2010) Ying Shen et al. CANCER BIOLOGY & THERAPY
- Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers
- (2010) Jeremy D. Henson et al. FEBS LETTERS
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
- Telomeres and Telomerase: From Discovery to Clinical Trials
- (2009) David R. Corey CHEMISTRY & BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started